CMIIU
Columbus Circle Capital Corp II UnitNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$422.97M
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$11.53
200-Day MA
$12.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Columbus Circle Capital Corp II Unit
CM Life Sciences II Inc (CMIIU) is a special purpose acquisition company (SPAC) focused on the life sciences sector, aimed at identifying and merging with innovative companies in biotechnology, pharmaceuticals, and healthcare. With a seasoned management team possessing extensive experience in investment and operational roles within the life sciences industry, CMIIU seeks to leverage its expertise to drive growth and create value for shareholders. The company is well-positioned to capitalize on emerging trends in healthcare, including advancements in therapeutics and diagnostics, as it explores potential partnerships and acquisition opportunities that align with its vision for sustainable innovation in life sciences.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $27.47M |
| % Insiders | 0.00% |
| % Institutions | 64.12% |
Data last updated: 4/10/2026